133 related articles for article (PubMed ID: 37145718)
21. Alvimopan: A cost-effective tool to decrease cystectomy length of stay.
Manger JP; Nelson M; Blanchard S; Helo S; Conaway M; Krupski TL
Cent European J Urol; 2014; 67(4):335-41. PubMed ID: 25667750
[TBL] [Abstract][Full Text] [Related]
22. Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.
Absher RK; Gerkin TM; Banares LW
Ann Pharmacother; 2010 Nov; 44(11):1701-8. PubMed ID: 20858770
[TBL] [Abstract][Full Text] [Related]
23. [ADOPTION OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL FOR THE MANAGEMENT OF PATIENTS UNDERGOING RADICAL CYSTECTOMY IN JAPAN].
Naito Y; Kanazawa H; Okada Y; Nagayama J; Syo N; Yamamoto A; Kojima I; Terashima Y; Nagai T
Nihon Hinyokika Gakkai Zasshi; 2020; 111(1):9-15. PubMed ID: 33473094
[TBL] [Abstract][Full Text] [Related]
24. Impact of Enhanced Recovery after Surgery
Grilo N; Crettenand F; Bohner P; Rodrigues Dias SC; Cerantola Y; Lucca I
Diagnostics (Basel); 2024 Jan; 14(3):. PubMed ID: 38337779
[TBL] [Abstract][Full Text] [Related]
25. Role of alvimopan (entereg) in gastrointestinal recovery and hospital length of stay after bowel resection.
Wang S; Shah N; Philip J; Caraccio T; Feuerman M; Malone B
P T; 2012 Sep; 37(9):518-25. PubMed ID: 23066346
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of alvimopan use in benign urinary tract reconstruction.
Hensley P; Higgins M; Rasper A; Ziada A; Strup S; Coleman C; Ruf K; Gupta S
Int Urol Nephrol; 2021 Jan; 53(1):77-82. PubMed ID: 32869174
[TBL] [Abstract][Full Text] [Related]
27. Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
Jang J; Kwok B; Zhong H; Xia Y; Grucela A; Bernstein M; Remzi F; Hudesman D; Chen J; Axelrad J; Chang S
Dig Dis Sci; 2020 Apr; 65(4):1164-1171. PubMed ID: 31522323
[TBL] [Abstract][Full Text] [Related]
28. Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study.
Zhang H; Wang H; Zhu M; Xu Z; Shen Y; Zhu Y; Xu Y; Chen W; Miao C
Eur J Surg Oncol; 2020 Jan; 46(1):202-208. PubMed ID: 31439358
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.
Ludwig K; Enker WE; Delaney CP; Wolff BG; Du W; Fort JG; Cherubini M; Cucinotta J; Techner L
Arch Surg; 2008 Nov; 143(11):1098-105. PubMed ID: 19015469
[TBL] [Abstract][Full Text] [Related]
30. Alvimopan Significantly Reduces Length of Stay and Costs Following Colorectal Resection and Ostomy Reversal Even Within an Enhanced Recovery Protocol.
Hyde LZ; Kiely JM; Al-Mazrou A; Zhang H; Lee-Kong S; Kiran RP
Dis Colon Rectum; 2019 Jun; 62(6):755-761. PubMed ID: 30807457
[TBL] [Abstract][Full Text] [Related]
31. Alvimopan addition to a standard perioperative recovery pathway.
Itawi EA; Savoie LM; Hanna AJ; Apostolides GY
JSLS; 2011; 15(4):492-8. PubMed ID: 22643504
[TBL] [Abstract][Full Text] [Related]
32. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.
Delaney CP; Weese JL; Hyman NH; Bauer J; Techner L; Gabriel K; Du W; Schmidt WK; Wallin BA;
Dis Colon Rectum; 2005 Jun; 48(6):1114-25; discussion 1125-6; author reply 1127-9. PubMed ID: 15906123
[TBL] [Abstract][Full Text] [Related]
33. Delayed gastrointestinal recovery after abdominal operation - role of alvimopan.
Berger NG; Ridolfi TJ; Ludwig KA
Clin Exp Gastroenterol; 2015; 8():231-5. PubMed ID: 26346889
[TBL] [Abstract][Full Text] [Related]
34. Alvimopan retains efficacy in patients undergoing colorectal surgery within an established ERAS program.
Brown S; McLoughlin J; Russ A; Casillas M; Buehler J; Heidel RE; Yates JR
Surg Endosc; 2022 Aug; 36(8):6129-6137. PubMed ID: 35043232
[TBL] [Abstract][Full Text] [Related]
35. Effect of alvimopan on return of bowel function after robot-assisted radical cystectomy.
Tobis S; Heinlen JE; Ruel N; Lau C; Kawachi M; Wilson T; Chan K
J Laparoendosc Adv Surg Tech A; 2014 Oct; 24(10):693-7. PubMed ID: 25180566
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Alvimopan Use in Laparoscopic Intra-abdominal Surgery: A Retrospective Review.
Kokan AA; Sheth S; Rogers K
Innov Pharm; 2021; 12(4):. PubMed ID: 36033128
[No Abstract] [Full Text] [Related]
37. Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial.
Baumgartner JM; Chen R; Messer K; Veerapong J; Kelly KJ; Ramamoorthy S; Lowy AM
J Am Coll Surg; 2022 Nov; 235(5):693-701. PubMed ID: 36102565
[TBL] [Abstract][Full Text] [Related]
38. Does alvimopan enhance return of bowel function in laparoscopic right colectomy?
Abodeely A; Schechter S; Klipfel A; Vrees M; Lagares-Garcia J
Am Surg; 2011 Nov; 77(11):1460-2. PubMed ID: 22196657
[TBL] [Abstract][Full Text] [Related]
39. Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
Earnshaw SR; Kauf TL; McDade C; Potashman MH; Pauyo C; Reese ES; Senagore A
J Am Coll Surg; 2015 Nov; 221(5):941-50. PubMed ID: 26353904
[TBL] [Abstract][Full Text] [Related]
40. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
